The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer?

SIMPLE SUMMARY: As immune checkpoint inhibitor (ICI) therapy against PD1 is only efficient in a small proportion of OSCC patients, identification of further checkpoints might improve therapy response by enabling combination ICI treatment. The aim of this study was to analyze the gene- and protein-ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Trumet, Leah, Weber, Manuel, Hahn, Alina, Kunater, Lina, Geppert, Carol, Glajzer, Jacek, Struckmeier, Ann-Kristin, Möst, Tobias, Lutz, Rainer, Kesting, Marco, Ries, Jutta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093349/
https://www.ncbi.nlm.nih.gov/pubmed/37046787
http://dx.doi.org/10.3390/cancers15072126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093349/
https://www.ncbi.nlm.nih.gov/pubmed/37046787
http://dx.doi.org/10.3390/cancers15072126

Ejemplares similares